Cargando…

From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)

BACKGROUND: Databases of prescription drug purchases are now widely used in pharmacoepidemiologic studies. Several methods have been used to generate drug use periods from drug purchases to investigate various aspects; e.g., to study associations between exposure and outcome. Typically, such methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanskanen, Antti, Taipale, Heidi, Koponen, Marjaana, Tolppanen, Anna-Maija, Hartikainen, Sirpa, Ahonen, Riitta, Tiihonen, Jari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382934/
https://www.ncbi.nlm.nih.gov/pubmed/25890003
http://dx.doi.org/10.1186/s12911-015-0140-z
_version_ 1782364647927578624
author Tanskanen, Antti
Taipale, Heidi
Koponen, Marjaana
Tolppanen, Anna-Maija
Hartikainen, Sirpa
Ahonen, Riitta
Tiihonen, Jari
author_facet Tanskanen, Antti
Taipale, Heidi
Koponen, Marjaana
Tolppanen, Anna-Maija
Hartikainen, Sirpa
Ahonen, Riitta
Tiihonen, Jari
author_sort Tanskanen, Antti
collection PubMed
description BACKGROUND: Databases of prescription drug purchases are now widely used in pharmacoepidemiologic studies. Several methods have been used to generate drug use periods from drug purchases to investigate various aspects; e.g., to study associations between exposure and outcome. Typically, such methods have been fairly simplistic, with fixed assumptions of drug use pattern and or dose (for example, the assumed usage of 1 tablet per day). This paper describes a novel PRE2DUP method that constructs drug use periods from purchase histories, and verified by a validation based on an expert evaluation of the drug use periods generated by the method. METHODS: The PRE2DUP method is a novel approach based on mathematical modelling of personal drug purchasing behaviors. The method uses a decision procedure that includes each person’s purchase history for each ATC code, processed in a chronological order. The method constructs exposure time periods and estimates the dose used during the period by considering the purchased amount in Defined Daily Doses (DDDs), which is recorded in the prescription register database. This method takes account of stockpiling of drugs, personal purchasing pattern; i.e., regularity of the purchases, and periods of hospital or nursing home care where drug use is not recorded in the prescription register. The method can be applied to a variety of drug classes with different doses and use patterns by controlling restriction parameters for each ATC class, or even each drug package. In the presented example, the PRE2DUP method was applied to a register-based MEDALZ-2005 study cohort. All drug purchases (3,793,085) recorded in the Finnish prescription register between 2002 and 2009 for persons with Alzheimer’s disease (28,093) were included. RESULTS: Results of the expert-opinion based validation indicate that PRE2DUP method creates drug use periods with a relatively high correctness. Drugs with varying patterns of use and drugs used on a short-term basis only require more precise parameters. CONCLUSIONS: PRE2DUP method gives highly accurate drug use periods for most drug classes, especially those meant for long-term use.
format Online
Article
Text
id pubmed-4382934
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43829342015-04-03 From prescription drug purchases to drug use periods – a second generation method (PRE2DUP) Tanskanen, Antti Taipale, Heidi Koponen, Marjaana Tolppanen, Anna-Maija Hartikainen, Sirpa Ahonen, Riitta Tiihonen, Jari BMC Med Inform Decis Mak Research Article BACKGROUND: Databases of prescription drug purchases are now widely used in pharmacoepidemiologic studies. Several methods have been used to generate drug use periods from drug purchases to investigate various aspects; e.g., to study associations between exposure and outcome. Typically, such methods have been fairly simplistic, with fixed assumptions of drug use pattern and or dose (for example, the assumed usage of 1 tablet per day). This paper describes a novel PRE2DUP method that constructs drug use periods from purchase histories, and verified by a validation based on an expert evaluation of the drug use periods generated by the method. METHODS: The PRE2DUP method is a novel approach based on mathematical modelling of personal drug purchasing behaviors. The method uses a decision procedure that includes each person’s purchase history for each ATC code, processed in a chronological order. The method constructs exposure time periods and estimates the dose used during the period by considering the purchased amount in Defined Daily Doses (DDDs), which is recorded in the prescription register database. This method takes account of stockpiling of drugs, personal purchasing pattern; i.e., regularity of the purchases, and periods of hospital or nursing home care where drug use is not recorded in the prescription register. The method can be applied to a variety of drug classes with different doses and use patterns by controlling restriction parameters for each ATC class, or even each drug package. In the presented example, the PRE2DUP method was applied to a register-based MEDALZ-2005 study cohort. All drug purchases (3,793,085) recorded in the Finnish prescription register between 2002 and 2009 for persons with Alzheimer’s disease (28,093) were included. RESULTS: Results of the expert-opinion based validation indicate that PRE2DUP method creates drug use periods with a relatively high correctness. Drugs with varying patterns of use and drugs used on a short-term basis only require more precise parameters. CONCLUSIONS: PRE2DUP method gives highly accurate drug use periods for most drug classes, especially those meant for long-term use. BioMed Central 2015-03-25 /pmc/articles/PMC4382934/ /pubmed/25890003 http://dx.doi.org/10.1186/s12911-015-0140-z Text en © Tanskanen et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tanskanen, Antti
Taipale, Heidi
Koponen, Marjaana
Tolppanen, Anna-Maija
Hartikainen, Sirpa
Ahonen, Riitta
Tiihonen, Jari
From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
title From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
title_full From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
title_fullStr From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
title_full_unstemmed From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
title_short From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
title_sort from prescription drug purchases to drug use periods – a second generation method (pre2dup)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382934/
https://www.ncbi.nlm.nih.gov/pubmed/25890003
http://dx.doi.org/10.1186/s12911-015-0140-z
work_keys_str_mv AT tanskanenantti fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup
AT taipaleheidi fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup
AT koponenmarjaana fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup
AT tolppanenannamaija fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup
AT hartikainensirpa fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup
AT ahonenriitta fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup
AT tiihonenjari fromprescriptiondrugpurchasestodruguseperiodsasecondgenerationmethodpre2dup